The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical validation of a multi-modal Ataraxis AI platform for recurrence prediction in early-stage breast cancer across multiple patient cohorts.
 
Jan Witowski
Employment - Ataraxis AI
Leadership - Ataraxis AI
Stock and Other Ownership Interests - Ataraxis AI
Patents, Royalties, Other Intellectual Property - Ataraxis AI
 
Khalil Choucair
No Relationships to Disclose
 
Jailan Elayoubi
No Relationships to Disclose
 
Elena Chiru
No Relationships to Disclose
 
Nancy Chan
Honoraria - Daiichi Sankyo/Astra Zeneca; Novartis
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Merck
 
Young-Joon Kang
No Relationships to Disclose
 
Frederick Howard
Consulting or Advisory Role - Novartis
 
Irina Ostrovnaya
Consulting or Advisory Role - Ataraxis
 
Freya Schnabel
Consulting or Advisory Role - Atarais AI; ClearCut Medical
Patents, Royalties, Other Intellectual Property - U.S. Nonprovisional Patent Application No. 17/560,916, filed December 23, 2021 (Claiming priority to U.S. Provisional Patent Application No. 63/130,484, filed December 24, 2020) Title: “SYSTEM AND METHOD FOR IMPLANT PRODUCTION” By: Kalle Levon, et al.
 
Waleed Abdulsattar
No Relationships to Disclose
 
Yu Zong
No Relationships to Disclose
 
Lina Daoud
No Relationships to Disclose
 
Marcus Vetter
No Relationships to Disclose
 
Jia Wern Pan
No Relationships to Disclose
 
Arvydas Laurinavicius
No Relationships to Disclose
 
Brian Piening
Consulting or Advisory Role - Lilly
Research Funding - Illumina (Inst); Loxo/Lilly (Inst); Shimadzu (Inst)
Patents, Royalties, Other Intellectual Property - System and Method for Automatic Labeling of Pathology Images. Patent pending. Matlock, Srinivasa, Bifulco, Piening inventors. Institutions: Omics Data Automation and Providence (Inst)
 
Carlo Bifulco
Stock and Other Ownership Interests - Bio-AI Health; Primevax
Honoraria - Illumina
Consulting or Advisory Role - Agilent; Incendia Pharmaceuticals AB; Lunaphore Technologies; Roche; Sanofi
Research Funding - Illumina (Inst)
Patents, Royalties, Other Intellectual Property - 32898 US2 - U.S. Patent Application No. 15/910972 filed March 2, 2018
(OPTIONAL) Uncompensated Relationships - Bio-AI Health; PrimeVax; SironaDx
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; General Electric; Gilead Sciences; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Expert Testimony - Pfizer; Sanofi
 
Francisco Esteva
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Genzyme
 
Lajos Pusztai
Stock and Other Ownership Interests - Ataraxis
Honoraria - Agendia; AstraZeneca; Bristol-Myers Squibb; Merck @ Co; natera; Radionetics
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol Myers Squibb; Merck; Natera; Personalis; Radionetics
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Menarini (Inst); Merck (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Foundation Medicine